Skip to content

Application and Efficacy Evaluation of TPS Management Model in Lower Extremity Arteriosclerosis Obliterans (ASO)

Application and Efficacy Evaluation of TPS Management Model in Lower Extremity Arteriosclerosis Obliterans (ASO)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113499
Enrollment
Unknown
Registered
2025-11-28
Start date
2025-12-31
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Arteriosclerosis Obliterans (ASO)

Interventions

TPS Intervention group:Comprehensive Preoperative Pain and Risk Assessment: Conducted jointly by pain specialists and vascular surgeons to identify high-risk factors such as chronic pain and psycholog

Sponsors

West China Tianfu Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years and =70% (by DSA, CTA, or MRA); 4. Fontaine Stage III-IV (rest pain or tissue loss); 5. Presence of chronic ischemic pain preoperatively (NRS score >=4 lasting for >=1 month); 6. Scheduled to undergo revascularization surgery (open bypass or endovascular therapy); 7. Proficient in using a smartphone to complete an electronic pain diary.

Exclusion criteria

Exclusion criteria: 1. Cognitive impairment; 2. Patients undergoing emergency surgery; 3. History of chronic pain syndromes (e.g., pain due to lumbar disc herniation); 4. History of severe psychological/psychiatric disorders, depression, or other mental illnesses; 5. Patients who do not undergo surgery after admission; 6. Patients directly transferred to the ICU postoperatively; 7. Language or communication barriers.

Design outcomes

Primary

MeasureTime frame
Ankle-Brachial Index;Clinical Staging / Fontaine Classification;Activities of Daily Living;Limb Pain Intensity;6-Minute Walk Distance (6MWD);

Secondary

MeasureTime frame
Bleeding Risk;

Countries

China

Contacts

Public ContactZerong Xie

West China Tianfu Hospital of Sichuan University

329556349@QQ.com+86 138 8060 0809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026